|
LSM14A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.179600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.106800E-01 |
| Normal-vs-Stage2 |
7.494000E-01 |
| Normal-vs-Stage3 |
3.162200E-01 |
| Normal-vs-Stage4 |
6.457000E-01 |
| Stage1-vs-Stage2 |
8.599000E-01 |
| Stage1-vs-Stage3 |
2.035800E-01 |
| Stage1-vs-Stage4 |
5.131000E-01 |
| Stage2-vs-Stage3 |
2.742600E-01 |
| Stage2-vs-Stage4 |
5.163200E-01 |
| Stage3-vs-Stage4 |
7.295000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.536000E-01 |
| Normal-vs-AfricanAmerican |
9.735400E-01 |
| Normal-vs-Asian |
8.811200E-01 |
| Caucasian-vs-AfricanAmerican |
8.663000E-01 |
| Caucasian-vs-Asian |
9.387000E-01 |
| AfricanAmerican-vs-Asian |
8.740800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.653000E-01 |
| Normal-vs-Female |
1.678200E-01 |
| Male-vs-Female |
7.745800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.191600E-01 |
| Normal-vs-Extreme_Weight |
6.893600E-01 |
| Normal-vs-Obese |
1.757030E-01 |
| Normal-vs-Extreme_Obese |
3.145400E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.133200E-01 |
| Normal_Weight-vs-Obese |
1.065020E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.976800E-01 |
| Extreme_Weight-vs-Obese |
1.455240E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.216400E-01 |
| Obese-vs-Extreme_Obese |
2.170000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.047400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.826630E-01 |
| Normal-vs-Age(61-80Yrs) |
4.014000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.549900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.470000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.615820E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.135900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.665900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.898300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.161200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.679200E-01 |
| Normal-VS-Type2 PRCC |
2.701200E-01 |
| Normal-VS-KIRP CIMP |
2.462800E-01 |
| Normal-VS-Unclassified PRCC |
6.834200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.450400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.369600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.556200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.040620E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.645400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.745200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.401400E-01 |
| Normal-vs-N1 |
5.913900E-02 |
| Normal-vs-N2 |
4.289400E-01 |
| N0-vs-N1 |
8.179700E-02 |
| N0-vs-N2 |
8.302800E-01 |
| N1-vs-N2 |
2.404200E-01 |
|
|
